Phytocannabinoid-Rich Oil for Chronic Pain Management in Elderly Cats with Osteoarthritis
chronic pain; feline osteoarthritis; phytocannabinoids; feline medicine; geriatric cats.
Chronic pain is a significant clinical challenge in feline medicine, particularly among elderly cats with osteoarthritis (OA), a progressive and degenerative condition that impairs joint function and reduces quality of life. Early diagnosis is hindered by the feline species’ behavioral tendency to mask clinical signs. In this context, alternative therapies such as phytocannabinoids have gained interest due to their action on the endocannabinoid system, with potential analgesic and anti-inflammatory properties. This prospective, randomized, double-blind, crossover clinical trial aimed to evaluate the efficacy of a phytocannabinoid-rich oil in managing osteoarthritic pain in geriatric cats. Thirty-one cats were initially enrolled, and twenty completed the full protocol. The average age of the cats was 12.7 years, and body weight ranged from 2.54 kg to 7.77 kg. The oil was well tolerated by most patients, and adverse effects were mild, self-limiting, and did not require discontinuation of treatment. These findings contribute to the assessment of the safety profile of phytocannabinoids in geriatric cats with osteoarthritis.